Skip to content
2000
Volume 10, Issue 4
  • ISSN: 2210-3031
  • E-ISSN: 2210-304X

Abstract

Formulation development of BCS Class II and IV drugs is a challenging task due to their poor solubility and permeability issue. An extensive literature survey was conducted to explore the relevant pharmaceutical approaches that have been used for solving the issue of poor solubility and permeability in the recent past. It has been found that a plethora of approaches have been investigated for addressing the issue of poor solubility and or permeability. These include physical modifications (modification of crystal habit, particle size reduction, complexation, polymorphism and drug dispersion in carriers), chemical modifications (salt formation), and formulation modifications (Nanotechnology-based approaches and hydrotropy). The physical and chemical modification approaches can be effectively used to enhance the solubility and dissolution rate of poorly soluble drugs, but the additional problem of poor permeability has been better addressed by lipid-based drug delivery systems. As the latter presents the drug in the solubilized state, bypass first-pass effects, circumvent the effect of Para-glycoprotein mediated efflux of drugs, hence contributing to overall bioavailability enhancement.

Loading

Article metrics loading...

/content/journals/ddl/10.2174/2210303110999200712185109
2020-12-01
2025-06-15
Loading full text...

Full text loading...

/content/journals/ddl/10.2174/2210303110999200712185109
Loading

  • Article Type:
    Review Article
Keyword(s): BCS; dissolution; Hydrophobic drugs; Nano lipid- carriers; permeability; solubility
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test